In addition, AML specific CTCF binding sites are correlated with cell fate genes and are enriched in key myeloid transcription factors involved in AML pathogenesis, including CEBPA, ETS1, PU.1 and RUNX1 [112]. This evidence concerns the gene CEBPA and acute myeloid leukemia.